OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HERNOB55

Herno Gin AB

Food Retail & DistributionVerified

Herno Gin AB maintains a strong liquidity position, as evidenced by a current ratio of 3.98, indicating that the company holds nearly four times more current assets than current liabilities. The company has no long-term debt and holds SEK 7,487,320 in cash and equivalents, which supports its low liquidity risk profile. The debt-to-equity ratio of 0.0 further underscores the company's conservative capital structure, with no leverage to complicate its balance sheet. In terms of profitability, Herno Gin AB reports a return on equity (ROE) of 4.48% and a return on assets (ROA) of 4.13%. These figures are in line with the industry's preferred metrics, which emphasize asset efficiency and equity returns. The company's operating income of SEK 5,915,020 and net income of SEK 4,923,580 reflect a healthy margin structure, with a gross profit of SEK 10,602,500 on total revenue of SEK 18,175,150. The company's revenue is not segmented by product or geographic region in the available data, but the absence of disclosed geographic diversification suggests a potential concentration risk. The company's operations are likely centered in its home market, which could expose it to regional economic fluctuations. Looking ahead, the company's revenue growth trajectory is not explicitly outlined in the available data. However, the absence of dilution or liquidity flags and the strong cash position suggest a stable financial outlook for the near term. The company's operating performance and capital structure indicate a conservative approach to growth, with no immediate plans for significant expansion or capital-intensive projects. The risk assessment for Herno Gin AB indicates a low probability of dilution and no immediate liquidity concerns. The company's financial structure is robust, with no long-term debt and a high current ratio. The absence of filing-based flags further supports the low-risk profile. The company's conservative capital structure and strong liquidity position reduce the likelihood of near-term dilution, and no recent events suggest a need for equity issuance. No recent filings or transcripts are available to provide additional insight into the company's strategic direction or operational performance. The company's financial statements and risk assessment suggest a stable and conservative business model, with no immediate signs of distress or aggressive growth initiatives.

30-day price · HERNOB(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyHerno Gin AB
TickerHERNOB.ST
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Herno Gin AB operates in the Food & Drug Retailing industry, primarily generating revenue through the retail and distribution of food and drug products.

Classification. Herno Gin AB is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a classification confidence of 0.92.

Herno Gin AB maintains a strong liquidity position, as evidenced by a current ratio of 3.98, indicating that the company holds nearly four times more current assets than current liabilities. The company has no long-term debt and holds SEK 7,487,320 in cash and equivalents, which supports its low liquidity risk profile. The debt-to-equity ratio of 0.0 further underscores the company's conservative capital structure, with no leverage to complicate its balance sheet. In terms of profitability, Herno Gin AB reports a return on equity (ROE) of 4.48% and a return on assets (ROA) of 4.13%. These figures are in line with the industry's preferred metrics, which emphasize asset efficiency and equity returns. The company's operating income of SEK 5,915,020 and net income of SEK 4,923,580 reflect a healthy margin structure, with a gross profit of SEK 10,602,500 on total revenue of SEK 18,175,150. The company's revenue is not segmented by product or geographic region in the available data, but the absence of disclosed geographic diversification suggests a potential concentration risk. The company's operations are likely centered in its home market, which could expose it to regional economic fluctuations. Looking ahead, the company's revenue growth trajectory is not explicitly outlined in the available data. However, the absence of dilution or liquidity flags and the strong cash position suggest a stable financial outlook for the near term. The company's operating performance and capital structure indicate a conservative approach to growth, with no immediate plans for significant expansion or capital-intensive projects. The risk assessment for Herno Gin AB indicates a low probability of dilution and no immediate liquidity concerns. The company's financial structure is robust, with no long-term debt and a high current ratio. The absence of filing-based flags further supports the low-risk profile. The company's conservative capital structure and strong liquidity position reduce the likelihood of near-term dilution, and no recent events suggest a need for equity issuance. No recent filings or transcripts are available to provide additional insight into the company's strategic direction or operational performance. The company's financial statements and risk assessment suggest a stable and conservative business model, with no immediate signs of distress or aggressive growth initiatives.
Key takeaways
  • Herno Gin AB maintains a strong liquidity position with a current ratio of 3.98 and no long-term debt.
  • The company's ROE of 4.48% and ROA of 4.13% indicate solid profitability and asset efficiency.
  • The absence of dilution and liquidity flags supports a low-risk profile.
  • The company's financial structure is conservative, with no immediate plans for expansion or capital-intensive projects.
  • No recent events or filings suggest a need for equity issuance or significant operational changes.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySEK
Revenue$18.2M
Gross profit$10.6M
Operating income$5.9M
Net income$4.9M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets$119.3M
Total liabilities$9.5M
Total equity$109.9M
Cash & equivalents$7.5M
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4
FY-3
FY-2
FY-1$50.3M$6.1M$6.6M-$28.3M
FY0$47.4M$3.5M$4.4M$111.5k
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4
FY-3
FY-2
FY-1$118.9M$110.9M$14.0M
FY0$124.3M$113.7M$8.6M
PeriodOCFCapExFCFSBC
FY-4
FY-3
FY-2
FY-1$7.5M-$37.1M-$28.3M
FY0$8.4M-$6.5M$111.5k
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$18.2M$5.9M$4.9M
FQ-6$10.3M-$405.0k$34.9k
FQ-5$11.0M-$476.8k$723.3k
FQ-4$11.1M$1.8M$1.9M$2.4M
FQ-3$10.6M$35.6k$483.2k$883.8k
FQ-2$13.0M$2.1M$2.1M-$585.2k
FQ-1$12.8M-$396.4k-$3.6k-$2.6M
FQ0$12.4M-$463.4k$69.3k-$693.2k
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$119.3M$109.9M$7.5M
FQ-6$117.5M$109.9M$10.1M
FQ-5$118.9M$110.9M$14.0M
FQ-4$120.2M$112.7M$15.2M
FQ-3$122.6M$113.2M$15.0M
FQ-2$126.5M$115.3M$16.4M
FQ-1$124.3M$113.7M$8.6M
FQ0$124.8M$113.7M$5.6M
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5$7.5M-$37.1M
FQ-4$1.1M-$9.2k$2.4M
FQ-3$1.0M-$125.3k$883.8k
FQ-2$5.6M-$3.3M-$585.2k
FQ-1$8.4M-$6.5M-$2.6M
FQ0-$1.4M-$1.6M-$693.2k
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$109.9M
Net cash$7.5M
Current ratio4.0
Debt/Equity0.0
ROA4.1%
ROE4.5%
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricHERNOBActivity
Op margin32.5%3.1% medp25 1.2% · p75 6.8%top quartile
Net margin27.1%2.0% medp25 0.7% · p75 4.1%top quartile
Gross margin58.3%26.1% medp25 17.2% · p75 32.0%top quartile
CapEx / revenue-2.5% medp25 -4.6% · p75 -1.4%
Debt / equity0.0%56.0% medp25 16.8% · p75 121.1%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-16 22:14 UTC#dee1c914
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 02:55 UTCJob: 1f4f90dc